Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMMLQAS)

Drug Name

(-)-deprenyl Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Alopecia	ED70	Patented	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Monoamine oxidase (MAO)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Moclobemide	DMNZWL7	Depression	6A70-6A7Z	Approved	[1]
Phenelzine	DMHIDUE	Depression	6A70-6A7Z	Approved	[1]
Tranylcypromine	DMGB5RE	Major depressive disorder	6A70.3	Approved	[1]
Selegiline	DM6034S	Major depressive disorder	6A70.3	Approved	[1]
Methylene blue	DMJAPE7	Acquired methemoglobinemia	3A93	Approved	[2]
Clorgyline	DMCEUJD	Parkinson disease	8A00.0	Approved	[1]
Pargyline	DMM0HR1	Hypertension	BA00-BA04	Approved	[1]
Ergoloid mesylate	DMORPBA	Alzheimer disease	8A20	Approved	[3]
Cyclopropylamine derivative 11	DMMJ0YN	N. A.	N. A.	Patented	[4]
PMID27019002-Compound-20a	DMRX748	N. A.	N. A.	Patented	[4]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):91-110.
2	Photoluminescence of CdTe nanocrystals modulated by methylene blue and DNA. A label-free luminescent signaling nanohybrid platform. Phys Chem Chem Phys. 2009 Jul 7;11(25):5062-9.
3	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
4	LSD1 inhibitors: a patent review (2010-2015).Expert Opin Ther Pat. 2016 May;26(5):565-80.